Studies have found that the expression of ANXA1 is downregulated in ovarian cancer, and the overexpression of ANXA1 is an independent predictor of prolonged overall survival (OS) in ovarian cancer patients (12, 14). The gene discussed is ANXA1; the disease is ovarian carcinoma.